{"id":140026,"date":"2022-05-31T19:24:17","date_gmt":"2022-06-01T00:24:17","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/05\/screening-every-five-years-safe-for-women-who-test-negative-for-hpv-study-confirms"},"modified":"2022-05-31T19:24:17","modified_gmt":"2022-06-01T00:24:17","slug":"screening-every-five-years-safe-for-women-who-test-negative-for-hpv-study-confirms","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/05\/screening-every-five-years-safe-for-women-who-test-negative-for-hpv-study-confirms","title":{"rendered":"Screening every five years safe for women who test negative for HPV, study confirms"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/screening-every-five-years-safe-for-women-who-test-negative-for-hpv-study-confirms.jpg\"><\/a><\/p>\n<p>A study of 1.3 million women in England has provided evidence to support the extension of cervical cancer screening intervals from three years to five years for those that have a negative screen result.<\/p>\n<p>The study, published today in the <i>British Medical Journal<\/i> by researchers from King\u2019s College London and funded by Cancer Research UK, provides reassurance to women and people with a cervix aged 24\u201349 years who test negative for the human papillomavirus (HPV), that screening at five-year intervals prevents as many cancers as screening at three-year intervals, even if they are not vaccinated against HPV.<\/p>\n<p>The study confirms that women in this age group are much less likely to develop clinically relevant cervical lesions (high-grade <a href=\"https:\/\/medicalxpress.com\/tags\/cervical+intraepithelial+neoplasia\/\" rel=\"tag\" class=\"\">cervical intraepithelial neoplasia<\/a>, which are abnormal changes of the cells that line the cervix and are otherwise known as CIN3+) and cervical cancer, three years after a negative HPV screen compared to a negative smear test. This risk is more than halved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A study of 1.3 million women in England has provided evidence to support the extension of cervical cancer screening intervals from three years to five years for those that have a negative screen result. The study, published today in the British Medical Journal by researchers from King\u2019s College London and funded by Cancer Research UK, [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-140026","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/140026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=140026"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/140026\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=140026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=140026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=140026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}